Ahmed Sabt

16PUBLICATIONS
29CO-AUTHORS
Biomolecular modelling and designNanotoxicology, health and safetyCheminformatics and quantitative structure-activity relationshipsMedical devicesMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 15, 2026
Development of isonicotinoyl-azole hybrids as potential InhA inhibitors for anti-tubercular activity.

|Jul 14, 2026
Discovery of novel anti-Toxoplasma gondii agent derived from thiazolidinone-isatin hybrids: synthesis, biological assessment, and computational modeling.

|Jul 13, 2026
Imidazopyridine derivatives as promising anti-Toxoplasma gondii agents: in vitro studies, in vivo testing, and molecular modeling analysis.

|Jun 18, 2026
Identification of Quinoline Tethered Thiadiazole/Thiazole Derivatives as Potent Tyrosinase Inhibitors With Promising Anti-Toxoplasma gondii Agents: Design, Synthesis, and Computational Analysis.

|Mar 23, 2026
Investigation of Potent Anti-Mycobacterium tuberculosis Agents Derived from Pyridine Derivatives Targeting the Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Computational Analysis.

Ahmed Sabt, Małgorzata Korycka-Machala, Asmaa F Kassem

|Feb 06, 2026
Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti-Mycobacterium tuberculosis agents.

Ahmed Sabt, Małgorzata Korycka-Machała, Asmaa F Kassem

Pageof 3

Frequent Collaborators

8 joint publications

Wagdy M Eldehna

7 joint publications

Hoda Atef Abdelsattar Ibrahim

5 joint publications

Jarosław Dziadek

3 joint publications

Hanaa Farag